Integris Wealth Management LLC Reduces Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Integris Wealth Management LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 11.5% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 484 shares of the healthcare conglomerate’s stock after selling 63 shares during the quarter. Integris Wealth Management LLC’s holdings in UnitedHealth Group were worth $246,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the company. KFG Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 5.1% during the second quarter. KFG Wealth Management LLC now owns 1,118 shares of the healthcare conglomerate’s stock worth $569,000 after purchasing an additional 54 shares in the last quarter. WestHill Financial Advisors Inc. purchased a new stake in shares of UnitedHealth Group during the 2nd quarter valued at $221,000. Raymond James & Associates grew its position in UnitedHealth Group by 1.1% in the second quarter. Raymond James & Associates now owns 1,774,308 shares of the healthcare conglomerate’s stock worth $903,584,000 after acquiring an additional 18,518 shares in the last quarter. Signet Investment Advisory Group Inc. raised its position in UnitedHealth Group by 7.0% during the second quarter. Signet Investment Advisory Group Inc. now owns 6,342 shares of the healthcare conglomerate’s stock valued at $3,230,000 after purchasing an additional 416 shares in the last quarter. Finally, Marietta Wealth Management LLC raised its stake in shares of UnitedHealth Group by 3.9% during the second quarter. Marietta Wealth Management LLC now owns 15,937 shares of the healthcare conglomerate’s stock worth $8,116,000 after acquiring an additional 596 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by insiders.

Analysts Set New Price Targets

UNH has been the topic of several recent research reports. Robert W. Baird raised their price target on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. Truist Financial upped their price target on shares of UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Tuesday, August 13th. HSBC raised their target price on UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. Finally, UBS Group lifted their price objective on UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research report on Thursday, July 18th. One analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $614.17.

UnitedHealth Group Stock Down 0.3 %

Shares of UnitedHealth Group stock traded down $1.93 during midday trading on Friday, hitting $577.68. The company had a trading volume of 2,728,939 shares, compared to its average volume of 4,224,914. The company has a 50 day moving average of $529.38 and a 200 day moving average of $507.42. The stock has a market capitalization of $533.44 billion, a P/E ratio of 35.31, a P/E/G ratio of 1.61 and a beta of 0.59. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $591.54. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.85 and a current ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.66 by $0.14. The firm had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. UnitedHealth Group’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.14 EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.45%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s payout ratio is 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.